Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @EFIS_Immunology
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EFIS_Immunology
-
Want to know more about a modular CAR T cell approach? This article by Michael Bachmann is currently the most downloaded article of the EFIS journal Immunology Letters and it's Open Acess! https://www.sciencedirect.com/science/article/pii/S0165247819300458 …pic.twitter.com/fV2E8VVNlW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EFIS wishes everyone a happy and successful New Year! The next exciting EFIS on TOUR meetings are already in preparation. Sign up for our Newsflash to stay tuned! https://buff.ly/2x4EIby
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Have you already browsed EJI's December issue? It features two interesting articles on tumor-infiltrating lymphocytes (https://buff.ly/2EOXDet and https://buff.ly/38XYHKD ) and much more. https://buff.ly/2rbfvwD pic.twitter.com/YeZGjiBAA8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The application deadline for the ACTERIA Doctoral Thesis Prizes (consisting of €30,000 prize money and €150,000 for a 3-year research project) is fast approaching. Make sure to apply until December 31, 2019! More information: https://www.acteriaprizes.net pic.twitter.com/xPBwoQTVhK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you interested in knowing more about the kind of articles published in the official EFIS journal Immunology Letters? Why not have a look at some of the most recently published articles to get a better idea. Enjoy reading!https://buff.ly/35l2MWM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EFIS on Tour with the support of BD Biosciences has kicked off in Prague with a great talk by Prof James Di Santopic.twitter.com/WI1uUfJhDT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fantastic resource, particularly for undergrad and MSc students, now available in Spanish! Great work
@SEinmunologia!https://twitter.com/britsocimm/status/1189550492394938369 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The EFIS NewsFlash has been sent out! For those who missed out on signing up for this edition, check out the online version at https://buff.ly/2C2ze3i . To not miss out on receiving future editions, sign up at https://buff.ly/2x4EIby . Enjoy reading!pic.twitter.com/GssGw1GLUk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Just two months until the deadline for the ACTERIA Doctoral Thesis Prizes (consisting of €30,000 prize money and €150,000 for a 3-year research project). Don't miss out on this career changing opportunity - start your application today https://buff.ly/31DDBx9 pic.twitter.com/vKqadx8VTZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Fantastic resource now online from EJI: Guidelines for the use of flow cytometry and cell sorting in immunological studies https://buff.ly/2BwDwzZ . Citing the guidelines is a great way of showing you followed best practices. Spread the word to your colleagues!
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Starting soon: Go support your EFIS colleagues at the EFIS Guest Symposium "Immunity and Immunotherapy" at IUIS2019. Session runs from 12:30-14:30 in room 301AB. Wishing all presenters and participants a great time!pic.twitter.com/i4kSbdr1qz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
To all those attending the IUIS2019 congress in Beijing, please support the young scientists presenting at the EFIS Guest Symposium "Immunity and Immunotherapy" by going along to the session on Monday 21 October from 12:30-14:30 in room 301AB.pic.twitter.com/WojkdSJcRI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A great end to the EFIS on TOUR meeting today. It was great to announce the collaboration between EFIS and BD for this and future on TOUR meetings. Thanks to all the organizers and participants for such a fruitful meeting.pic.twitter.com/XmAmIegJJL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A great start to the EFIS on TOUR meeting at Istanbul University this morningpic.twitter.com/VSykg2N99Q
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It will be a busy few days for the EFIS Board. Meeting number one - the Board Meeting - taking place now in Istanbul. Looking forward to the EFIS on TOUR meeting tomorrow.pic.twitter.com/j6A2phKphc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Have you heard that the ACTERIA prizes awarded by EFIS will now be awarded on an annual basis? The call for applications for the ACTERIA Doctoral Thesis Prizes opens on October 1st. Be sure to check out the full details on these amazing prizes at https://buff.ly/31DDBx9 .pic.twitter.com/yKfc98uQAS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EFIS proslijedio/la je Tweet
Please RT! One week to our 2019 ISI meeting! Watch Ed Lavelle, president
@Irishimmunology and Annie Curtis, host@RCSI, talk about the highlights of this year meeting. https://www.youtube.com/watch?v=5cbaJgvC4bM …@tcddublin@tcdTBSI@ucddublin@UCC@QUBelfast@nuigalway@EFIS_ImmunologyPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Best of luck to all those participating in the II Joint Meeting of the DGfl and the SIICA starting today in Munich. Don't miss the EFIS Symposium on epigenetics and posttranscriptional regulation on Sep 11, 2019, 13.00–14.30. See https://buff.ly/2OfgmXZ for more details.pic.twitter.com/GbkgEfufp6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EFIS proslijedio/la je Tweet
*Abstract submission reminder* We have an exciting 4-day programme planned for
#BSI19 & we don't want anyone to miss the chance to be a part of it! Please share this with the#immunology community
#1daytogo
Submit here: http://bsicongress.com pic.twitter.com/gLin8PAfg4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EFIS proslijedio/la je Tweet
Accomplishing Rudolf Virchow's dream – “Single- Cell Medicine" in chronic diseases. Dr. Mir-Farzin Mashreghi from the
#DRFZ presents#single-cell medicine at@FuturiumD opening.@LeibnizWGL@Mashreghi_DRFZ@RESTOREhorizonpic.twitter.com/6dQCt8VEQn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Our 